Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to determine early detection of concussion for those at risk of developing symptoms and to be able to detect subconcussive cerebral impairment, and thus gaining a better understanding of the injury patterns for concussions in Men's and Women's Collegiate sports.


Clinical Trial Description

Description of the Research Subjects will be members of NYIT's Collegiate Athletic Teams. Potential subjects will be informed about the proposed study and asked if the athlete is interested in participating. If the athlete agrees, the key investigator will review the study procedures, what is expected of the subject, and complete the informed consent process. Participation will be completely voluntary and will have no impact on the quality of care the subject will receive. Inclusion and exclusion criteria will then be evaluated by the key investigator to determine if the subject is qualified to participate in this study. Following consent and review of inclusion and exclusion criteria, the subject will be assigned a subject identification number in which is intended to maintain confidentiality of the subject's personal health information. The number will be used for the duration of the study and in all analyses. Once enrolled, the subjects will complete a baseline questionnaire* that will include demographic information and personal history, as well as consent for de-identified information to be shared with a third party, Quadrant Biosciences, for research purposes. The subjects will be evaluated by a series of measurements, ClearEdge, Quadrant Bioscience Salivary Testing, King Devick, and Im PACT, in the preseason, midseason, and postseason, or if they are suspected of a concussion by the athletic trainer or team physician. Visit 1: Baseline Data Collection - Assessment Tools - Demographic/Baseline questionnaire* - ImPACT - King-Devick - ClearEdge New York Institute of Technology Institutional Review Board Approved From 07/18/20 to 07/17/21 - Quadrant Bioscience Salivary Testing - Quadrant Bioscience Salivary Testing Questionnaire - Estimated Time: 1.5 hours Visit 2: Mid-Season Collection - Assessment Tools - ImPACT - King-Devick - ClearEdge - Quadrant Bioscience Salivary Testing - Quadrant Bioscience Salivary Testing Questionnaire - Estimated time: 1 hour Visit 3: Post-season Data Collection - Assessment Tools - ImPACT - King-Devick - ClearEdge - Quadrant Bioscience Salivary Testing - Quadrant Bioscience Salivary Testing Questionnaire - Estimated time: 1 hr Visit 4: If athlete is suspected to have sustained a concussion by the athletic trainer or team physician, the athlete will come for an additional visit - Assessment Tools - ImPACT - King-Devick - ClearEdge - Quadrant Bioscience Salivary Testing - Quadrant Bioscience Salivary Testing Questionnaire - Estimated time: 1 hr ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03394248
Study type Observational [Patient Registry]
Source New York Institute of Technology
Contact
Status Completed
Phase
Start date January 26, 2018
Completion date March 13, 2020

See also
  Status Clinical Trial Phase
Not yet recruiting NCT04696523 - Effect of Xenon on Brain Injury After Aneurysmal Subarachnoid Hemorrhage Phase 2
Recruiting NCT04908241 - Telerehabilitation With Aims to Improve Lower Extremity Recovery Post-Stroke (TRAIL-RCT) N/A
Recruiting NCT05931250 - Alternating and Direct Current Stimulation for Neuropathic Eye Pain N/A
Active, not recruiting NCT06018545 - AI Assisted Reader Evaluation in Acute Computed Tomography (CT) Head Interpretation
Recruiting NCT04907513 - Amotivational Syndrome and Fatigue in Neurosurgery
Completed NCT03523169 - Cerebral Oxygen Challenge of Passive Leg Raising Test in Sepsis
Recruiting NCT04574440 - Functional Near Infrared Spectroscopy in Adult Surgery